Your browser doesn't support javascript.
loading
Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder.
Aktas, Orhan; Hartung, Hans-Peter; Smith, Michael A; Rees, William A; Fujihara, Kazuo; Paul, Friedemann; Marignier, Romain; Bennett, Jeffrey L; Kim, Ho Jin; Weinshenker, Brian G; Pittock, Sean J; Wingerchuk, Dean M; Cutter, Gary; She, Dewei; Gunsior, Michele; Cimbora, Daniel; Katz, Eliezer; Cree, Bruce A.
Afiliación
  • Aktas O; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany orhan.aktas@uni-duesseldorf.de bruce.cree@ucsf.edu.
  • Hartung HP; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Smith MA; Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.
  • Rees WA; Department of Neurology, Medical University Vienna, Vienna, Austria.
  • Fujihara K; Department of Neurology, Palacky University in Olomouc, Olomouc, Czech Republic.
  • Paul F; Horizon Therapeutics plc, Gaithersburg, Maryland, USA.
  • Marignier R; Horizon Therapeutics plc, Gaithersburg, Maryland, USA.
  • Bennett JL; Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Koriyama, Fukushima, Japan.
  • Kim HJ; Multiple Sclerosis and Neuromyelitis Optica Center, Southern Tohoku Research Institute for Neuroscience, Koriyama, Japan.
  • Weinshenker BG; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité, Universitätsmedizin Berlin, Berlin, Germany.
  • Pittock SJ; Centre de Référence des Maladies Inflammatoires Rares du Cerveau et de la Moelle (MIRCEM), Service de Neurologie, Sclérose en Plaques, Pathologies de la Myéline et Neuro-inflammation, Hopital Neurologique et Neurochirurgical Pierre Wertheimer Centre de reference des syndromes neurologiques paraneopl
  • Wingerchuk DM; Departments of Neurology and Ophthalmology, Programs in Neuroscience and Immunology, University of Colorado - Anschutz Medical Campus, Aurora, Colorado, USA.
  • Cutter G; Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Republic of Korea.
  • She D; Department of Neurology, University of Virginia, Charlottesville, Virginia, USA.
  • Gunsior M; Department of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Cimbora D; Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA.
  • Katz E; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Cree BA; Horizon Therapeutics plc, Gaithersburg, Maryland, USA.
J Neurol Neurosurg Psychiatry ; 94(9): 757-768, 2023 09.
Article en En | MEDLINE | ID: mdl-37221052
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neuromielitis Óptica Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Neurol Neurosurg Psychiatry Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neuromielitis Óptica Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Neurol Neurosurg Psychiatry Año: 2023 Tipo del documento: Article